What is the Share Price of IOL Chemicals & Pharmaceuticals Ltd?
- Answer Field
-
The share price of IOL Chemicals & Pharmaceuticals Ltd for NSE is ₹ 64.79 and for BSE is ₹ 64.68.
BAJAJ BROKING
Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply
As of the latest trading session, IOL CHEM AND PHARMA LTD share price is currently at ₹ 64.79, which is down by ₹ -2.00 from its previous closing. Today, the stock has fluctuated between ₹ 63.65 and ₹ 66.60. Over the past year, IOL CHEM AND PHARMA LTD has achieved a return of -17.71 %. In the last month alone, the return has been 1.63 %. Read More...
Particulars | DEC 2024 (Values in Cr) |
---|---|
Revenue | 523.30 |
Operating Expense | 499.54 |
Net Profit | 20.55 |
Net Profit Margin (%) | 3.92 |
Earnings Per Share (EPS) | 3.50 |
EBITDA | 50.94 |
Effective Tax Rate (%) | 26.13 |
Company Name | Price | P/E | P/B | Market Cap | 52 Week Low/High |
---|---|---|---|---|---|
AMBALAL SARABHAI ENTERPRISES L | 36.46 | 19.60 | 1.99 | 279.41 | 34.11 / 77.70 |
BLISS GVS PHARMA LTD | 119.00 | 15.60 | 1.24 | 1253.91 | 92.25 / 184.95 |
CIPLA LTD | 1549.65 | 25.08 | 4.41 | 125155.99 | 1310.05 / 1702.00 |
FERMENTA BIOTECH LIMITED | 260.70 | 21.60 | 2.64 | 767.27 | 145.00 / 449.00 |
Company Name | Price | P/E | P/B | Market Cap | 52 Week Low/High |
---|---|---|---|---|---|
AMBALAL SARABHAI ENTERPRISES L | 36.46 | 21.96 | 6.19 | 279.41 | 34.11 / 77.70 |
AMRUTAJAN HEALTH LTD | 692.80 | 40.61 | 6.72 | 2002.93 | 548.05 / 861.40 |
ASTRAZENECA PHARMA IND LT | 8665.50 | 129.24 | 31.88 | 21663.75 | 5000.00 / 9199.00 |
BLISS GVS PHARMA LTD | 119.00 | 15.45 | 1.22 | 1253.91 | 92.25 / 184.95 |
IOL Chemicals and Pharmaceuticals Limited, incorporated in September, 1986 is a renowned company in the Active Pharmaceutical
Ingredient (API) and specialty chemicals sectors. With substantive manufacturing capacities, the Company benefits from economies
of scale and cost supremacy. Its extensive expertise in both API and specialty chemicals strengthens its business model and opens doors to diversified growth opportunities.
Within the API segment, IOL develops and supplies a wide range of essential products utilized by pharmaceutical companies worldwide for the production of key medicines. It serves as a global supplier of various APIs, including Ibuprofen, Metformin, Clopidogrel, Lamotrigine, Pantoprazole, and Fenofibrate, alongside other APIs, and maintains a significant presence in all major therapeutic categories.
In the Specialty Chemicals division, IOL manufactures Ethyl Acetate, Iso Butyl Benzene (IBB), Mono Chloro Acetic Acid (MCA), and Acetyl Chloride. The Company is a leader in fostering green chemistry through its extensive production of Ethyl Acetate, a sustainable and environmentally friendly solvent. As one of the largest manufacturers globally, the Company plays a vital role in promoting the adoption of eco-friendly practices in various industries such as pharmaceuticals, printing, flexible packaging, adhesives, surface coatings, flavors, paints & lamination, and essences.
The company has two manufacturing units namely API Unit and Chemical Unit located in Punjab. API Unit manufactures Ibuprofen with the installed Capacity of 10 MTPD. Chemical Unit manufactures organic chemicals such as Glacial Acetic Acid, Ethyl Acetate, Acetic Anhydride, Mono chloro acetic Acid, Acetyl Chloride and Iso butyl Benzene.
The company is having their presence in over 40 countries across the world, which includes Bangladesh, Thailand, UAE, Syria, Singapore, Hong Kong, Pakistan, Egypt, and many others. They have strong business relationships with a number of prestigious clients such as Ranbaxy Labs, Dr Reddy. DS Group, Cipla, Uflex Industries, ITC Ltd, ICI Paints, Asian Paints, Pidillte, Rallis India, Hindustan Polymide, Gujarat Super Phosphate and Avon Organics Ltd etc.
The capacity enhancement project and Multi Product PPIs Plant and other pharmaceutical intermediate products with a CAPEX of Rs 130 crore was completed in 2012. The Company undertook another project of multi product plant for manufacture active pharmaceutical ingredients and upgrading of R&D facilities involving a CAPEX of Rs 58.41 crore.
G Drugs and Pharmaceuticals Limited (GDPL) was merged with Company, through The Board for Industrial and Financial Reconstruction (BIFR), vide its order dated 15 March 2012, with appointed date of 1 April 2010. The said Merger was made effective on 20 April 2012 and consequently GDPL ceased to exit from that date.
During the current year 2016-17, the Company converted its existing multiple purpose plant into a dedicated ibuprofen manufacturing facility and resulting to its conversion, the ibuprofen manufacturing facility increased from 6200 TPA to 7200 TPA. During year 2017-18, Unit III to manufacture Fenofi brate, Clopidogrel and Lamotrigine Project was set up which costed Rs 16.48 crore. The company also setup Unit IV for manufacturing Metformin an anti-diabetic drug with a capacity of 3000 MT per annum with project cost of Rs 10.02 crore. It enhanced installed capacity of Ibuprofen from 7200 TPA to 10000 TPA by debottlenecking and re-engineering the plant in the month of August 2018.
During year 2019, the Company has enhanced installed capacity of Metformin from 3,000 TPA to 4,000 TPA with a capex of Rs 2.71 crore; it set up Unit V o manufacture Clopidogrel Bisulphate & Fenofibrate with a capacity of 180 MT per annum with capex of Rs 19.26 crore; it further enhanced existing manufacturing facilities of Ibuprofen from 10,000 TPA to 12,000 TPA and Iso Butyl Benzene from 9,000 TPA to 12,000 TPA in May 2019 with capex of Rs 12.10 crore. During 2020, the Company set up 'Unit VI', with an installed capacity of 240 MT per annum, which costed Rs 33.83 Crore, to manufacture 'Pantoprazole' and has started its trial production. During 2021, the Company set up an another Unit-7 for manufacturing Metformin with an additional capacity of 7,200 MT per annum for project costing Rs 28 cr. It installed new manufacturing facilities 'Unit-8' to manufacture Ibuprofen Derivatives and other Pharma Products during FY 2020-21. It increased existing manufacturing facilities of Ethyl Acetate from 87,000 MT per annum to 100,000 MT per annum in Chemical segment during 2021-22.
During the year 2022-23, IOL- Foundation was incorporated as wholly owned subsidiary company. The Company set up multi product manufacturing facilities Unit 10' for manufacturing pharma APIs. It identified to manufacture Fenofibrate, Lamotrigine etc in this unit. Further, it also initiated the project for installation of new manufacturing facilities (Unit-9) for manufacturing Gabapentin and other Pharma products during the year, which is under implementation.
In 2023-24, Company commenced the production of Acetic Anhydride' in the chemical division mainly for captive consumption as well as merchant sale with installed capacity of 25000 MTPA.
The share price of IOL Chemicals & Pharmaceuticals Ltd for NSE is ₹ 64.79 and for BSE is ₹ 64.68.
The market cap of IOL Chemicals & Pharmaceuticals Ltd for NSE is ₹ 3,80.35 Cr. and for BSE is ₹ 3,79.70 Cr. as of now.
The 52 Week High and Low of IOL Chemicals & Pharmaceuticals Ltd for NSE is ₹ 107.54 and ₹ 57.50 and for BSE is ₹ 107.41 and ₹ 57.51.
You can trade in IOL Chemicals & Pharmaceuticals Ltd shares with Bajaj Broking by opening a Demat Account.
The 1 year returns on the stock has been -17.71%.
IOL Chemicals & Pharmaceuticals Ltd share price is for NSE ₹ 64.79 & for BSE ₹ 64.68 as on Apr 30 2025 03:30 PM.
The market cap of IOL Chemicals & Pharmaceuticals Ltd for NSE ₹ 3,80.35 & for BSE ₹ 3,79.70 as on Apr 30 2025 03:30 PM.
As on Apr 30 2025 03:30 PM the price-to-earnings (PE) ratio for IOL Chemicals & Pharmaceuticals Ltd share is 19.48.
As on Apr 30 2025 03:30 PM, the price-to-book (PB) ratio for IOL Chemicals & Pharmaceuticals Ltd share is 56.51.
You can trade in IOL Chemicals & Pharmaceuticals Ltd shares with Bajaj Broking by opening a demat account.
To buy IOL Chemicals & Pharmaceuticals Ltd shares on the Bajaj Broking app, follow these steps:
• Login to the Bajaj Broking App
• Click on the Search Icon
• Search “IOL Chemicals & Pharmaceuticals Ltd”
• Click on the BUY icon
• Place a buy order specifying the desired quantity of shares.
• Click BUY again to complete the purchase
No results found